Business Context and Reporting Period
This Form 10-Q covers The Procter & Gamble Company for the quarterly period ended September 30, 1996 (First Quarter of Fiscal 1997). The company reported 681,966,608 shares of Common Stock outstanding as of October 18, 1996.
Key Financial Metrics
| Metric | Q1 1997 | Q1 1996 |
|---|---|---|
| Net Sales | $8,903 million | $9,027 million |
| Operating Income | $1,547 million | $1,435 million |
| Net Earnings | $979 million | $896 million |
| Diluted EPS | $1.30 | $1.18 |
| Gross Margin | 43.8% | 42.3% |
| Operating Margin | 17.4% | 15.9% |
| Cash from Operations | $1,443 million | $337 million |
| Cash and Equivalents (End) | $2,595 million | $1,589 million |
| Total Debt (Current + Long-term) | $5,730 million | Filing text does not provide a clear value |
Material Changes vs. Prior Period
- Revenue: Net sales decreased 1% to $8.9 billion, primarily due to unfavorable currency exchange rates (particularly in Japan and Germany). Worldwide unit volume grew 1%.
- Profitability: Net earnings increased 9% to $979 million. Gross and operating margins expanded significantly due to cost efficiencies and pricing actions.
- Cash Flow: Operating cash flow surged to $1.443 billion compared to $337 million in the prior year, driven by working capital management and earnings growth.
- Regional Performance:
- North America: Sales up 1%, earnings up 9%.
- Europe, Middle East, Africa: Sales down 1% (currency impact), earnings up 13%.
- Asia: Sales down 14% and earnings down 10% due to competitive pressures in Japan and ECR inventory adjustments.
- Latin America: Sales down 1%, earnings up 11% on improved margins.
Outlook, Risks, and Unusual Items
- Efficient Consumer Response (ECR): The rollout of ECR in Europe and Asia caused short-term inventory reductions and slowed sales growth, though management expects long-term margin improvements similar to the U.S. experience.
- Restructuring: A $2.4 billion restructuring reserve established in 1993 had a remaining balance of $610 million as of September 30, 1996. The program is expected to be substantially completed in the current fiscal year.
- Legal Proceedings: The company paid a $1 million civil penalty to the EPA to settle a matter regarding the Toxic Substances Control Act compliance audit program.
- Shareholder Action: A shareholder resolution to elect all directors annually was defeated. The appointment of Deloitte & Touche LLP as independent auditors was ratified.
Investor Verification Checklist
- Verify the sustainability of margin expansion (43.8% gross margin) amidst competitive pressures in Japan and Latin America.
- Monitor the impact of currency fluctuations on future sales, as unfavorable rates significantly impacted Q1 results.
- Assess the timeline and cost completion of the remaining $610 million restructuring reserve.
- Track the rebound of unit volume in China and Asia following ECR-related inventory adjustments.
- Review the effectiveness of pricing policies in Latin America to offset volume declines caused by economic conditions.